James T. Boyle Jr., EVP, CEO of Lab Corporate Diagnostics at LABORATORY CORP OF AMERICA HOLDINGS (LH), sold 6,173 shares at $101.67 ($630K) on 2016-02-12, disclosed to the SEC on 2016-02-16.
Seasonal sale ($630k) by EVP, CEO of Lab Corporate Diagnostics — this insider has traded LH in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $101.40 | 1,345 | $136K | 21.6% |
| 2 | $101.67 | 2,712 | $276K | 43.8% |
| 3 | $103.02 | 942 | $97K | 15.4% |
| 4 | $103.02 | 1,174 | $121K | 19.2% |
| Total | $102.07 avg | 6,173 | $630K | 100% |
| Filing → |
| LH | SELL | 2016-02-18 | $835K | — | Filing → |
| LH | SELL | 2015-04-27 | $176K | — | Filing → |
| LH | SELL | 2015-03-04 | $153K | — | Filing → |